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An increasing number of studies show that the activation of the innate immune system and inflammatory mechanisms
play an important role in the pathogenesis of numerous diseases. The innate immune system is present in almost all
multicellular organisms and its activation occurs in response to pathogens or tissue injury via pattern-recognition
receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) or danger-associated molecular
patterns (DAMPs). Intracellular pathways, linking immune and inflammatory response to ion channel expression and
function, have been recently identified. Among ion channels, the transient receptor potential (TRP) channels are a
major family of non-selective cation-permeable channels that function as polymodal cellular sensors involved in many
physiological and pathological processes.
In this review, we summarize current knowledge of interactions between immune cells and PRRs and ion channels
of TRP families with PAMPs and DAMPs to provide new insights into the pathogenesis of inflammatory diseases. TRP
channels have been found to interfere with innate immunity via both nuclear factor-kB and procaspase-1 activation
to generate the mature caspase-1 that cleaves pro-interleukin-1β cytokine into the mature interleukin-1β.
Sensory neurons are also adapted to recognize dangers by virtue of their sensitivity to intense mechanical, thermal and
irritant chemical stimuli. As immune cells, they possess many of the same molecular recognition pathways for danger. Thus,
they express PRRs including Toll-like receptors 3, 4, 7, and 9, and stimulation by Toll-like receptor ligands leads to induction
of inward currents and sensitization in TRPs. In addition, the expression of inflammasomes in neurons and the involvement
of TRPs in central nervous system diseases strongly support a role of TRPs in inflammasome-mediated neurodegenerative
pathologies. This field is still at its beginning and further studies may be required.
Overall, these studies highlight the therapeutic potential of targeting the inflammasomes in proinflammatory,
autoinflammatory and metabolic disorders associated with undesirable activation of the inflammasome by using specific
TRP antagonists, anti-human TRP monoclonal antibody or different molecules able to abrogate the TRP channel-mediated
inflammatory signals.
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The innate immune system plays an important role in the
host’s first line of defense against microbial infections and
involves the recognition of pathogen-associated molecular
patterns (PAMPs) or danger-associated molecular patterns
(DAMPs) by pattern recognition receptors (PRRs) [1,2]. Ac-
tivation of PRRs by microorganisms, toxins, chemical com-
pounds, cytoplasmic PAMPs and/or endogenous DAMPS
triggers intracellular signaling leading to inflammasome
generation.
The PRR family of the innate immune system comprises:
the membrane-bound Toll-like receptors (TLRs), C-type
lectin receptors, retinoid acid-inducible gene-1-like recep-
tors, and NOD-like receptors (NLRs; nucleotide-binding
oligomerization domain receptors) [3].
The TLR family comprises type I transmembrane proteins
with an extracellular binding domain composed of leucine-
rich repeats and intracellular Toll-interleukin (IL)-1 receptor
domains required for signals transduction [4,5]. Based on
the TLR cellular localization and PAMP ligands, this family
is divided into two groups. The first members (TLR3, TLR7,
TLR8, and TLR9) are located in the endoplasmic reticulum
(ER), endosomes and lysosomes; the second (TLR1, TLR2,
TLR4, TLR5, and TLR6) are expressed on cell membranes
and sense different PAMPs, including fungal cell wall com-
ponents, lipopolysaccharide (LPS), bacterial flagella and pep-
tidoglycan [6,7]. Upon activation, TLRs recruit a set of
adaptor molecules such as MyD88 and Toll-IL-1-receptor
domain-containing adaptor inducing interferon-β, and pro-
mote signaling events leading to the secretion of proinflam-
matory mediators [8].
The NLR family controls the inflammatory and immune
responses via the activation of different signaling pathways
involved in nuclear factor (NF)-κB activation (first signal)
and caspase-1-mediated cleavage of IL-1β and IL-18 cyto-
kines (second signals) [9]. NLR proteins share highly con-
served structures and are divided into several subfamilies
based on the nature of their N-terminal domains. NOD1
and NOD2 are two well-characterized members of non-
inflammasome NLRs, which mediate NF-κB and mitogen-
activated protein kinase activation in response to different
PAMPs [10].
Inflammasomes are involved in defensive responses, dan-
gerous inflammation and in pyroptosic cell death [11].
Structurally, the inflammasome is composed of the intracel-
lular adaptor protein ASC (apoptosis-associated speck-like
protein containing a CARD) that recruits caspase-1 to the
inflammasome complex and of a “sensor NLR” that func-
tions as a molecular scaffold for the activation of caspase-1
for the final secretion of IL-1β and IL-18 [12]. Upon binding
to the inflammasome, caspase-1 is cleaved and activated,
leading to cleavage of different targets and causing matur-
ation and secretion of the pro-inflammatory IL-1β. Several
types of inflammasomes have been described containingdifferent sensor proteins such as NLRP1, NLRP3, NLRP6,
NLRP12, NLRP6, retinoid acid-inducible gene-1, AIM-2 and
IPAF [9]. Among the NLR inflammasomes, the NLRP3 (nu-
cleotide-binding domain leucine-rich repeat containing fam-
ily, pyrin domain containing 3) is the most studied, and is
activated by a broad range of signals of pathogenic, en-
dogenous and environmental origin. NLRP3 is also activated
by endogenous danger signal molecules released as a conse-
quence of tissue injury, such as hyaluronan, extracellular
ATP, uric acid crystals and amyloid-β fibrils, industrial parti-
cles and nanoparticles such as alum, asbestos, silica and ti-
tanium dioxide [9,13]. The mechanisms that have been
suggested to mediate NLRP3 triggering are: potassium
efflux, reactive oxygen species (ROS) production and alter-
ation in the phagolysosomal [14,15] and lysosomal cathep-
sins activity [16]. In addition, the NLRP3 inflammasome
regulates insulin signaling, the plaque formation in athero-
sclerosis, myocardial ischemia-reperfusion injury and neuro-
degeneration [17-19]. Recent data strongly support an
important role played by the ion family of Transient Recep-
tor Potential (TRP) channels that mediates interchanged
and bidirectional contact and signaling with known PRRs,
PAMPs and DAMPs in triggering the first and second sig-
nals responsible for inflammasome activation [20].
The TRP channel family
TRP channels are a family of non-selective cation channels
that function as polymodal sensors in different physiological
[21] and pathological processes [22]. The TRP channels are
membrane proteins with six putative transmembrane seg-
ments (S1–S6) and a cation-permeable pore region between
S5 and S6. About 30 different mammalian TRP channels are
identified and classified into six subfamilies on the basis of
sequence homology: TRP canonical (TRPC; TRPC1-7), TRP
vanilloid (TRPV; TRPV1-6), TRP melastatin (TRPM;
TRPM1-8), TRP polycystin (TRPP; TRPP2, TRPP3, TRPP5),
TRP mucolipin (TRPML; TRPML1-3), and TRP ankyrin
(TRPA; TRPA1) [23]. The different TRPs show distinct cat-
ion selectivity and gating mechanisms [24], and they can be
opened by membrane depolarization, ligand binding, or G-
protein coupled signaling [25].
TRPCs consist of proteins related to the “canonical”
Drosophila TRP; functionally, the TRPC receptor family
has been implicated in hypertension, cardiac hypertrophy,
vascular inflammation, progressive kidney failure and can-
cer [26-29].
The TRPV channels are thermo- and chemo-sensitive
channels composed of six members [30]. TRPV1 can be
activated by a diverse range of stimuli, including
membrane depolarization, noxious heat, vanilloid, endo-
cannabinoids, extracellular protons and inflammatory
mediators [31]. TRPV1 plays a pivotal role in pain and
neurogenic inflammation [20]. Moreover, a role of this
receptor in glioblastoma and bladder cancer has been
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and Mg2+ [34,35].
Among TRPMs, TRPM1 functions as a tumor sup-
pressor, and TRPM3 seems to be involved in etiology of
amyotrophic lateral sclerosis [34]. TRPM2, TRPM4, and
TRPM5 are reported to be sensitive to high tempera-
tures. The best understood cold-sensitive TRP channel
is TRPM8, which is activated when the temperature
drops below about 20°C [35].
The TRPML subfamily consists of three members
characterized by a large E1 loop, between S1 and S2,
with several N-glycosylation sites.
The TRPP subfamily has three members, TRPP2,
TRPP3, and TRPP5; mutations in TRPP2 lead to auto-
somal dominant polycystic kidney disease [36].
The TRPA1 channel is the only member of the TRPA
subfamily; it is involved in pain and in chronic visceral
inflammation [37].
A plethora of diseases are interconnected with alter-
ation of the expression and function of TRP channels.
This review focuses attention on the aspects of the inter-
action between TRP channels and PRRs and PAMPs/
DAMPs in mediating inflammasome generation and
triggering an inflammatory response.
The TRP receptors recognize environmental
exogenous and endogenous danger signals
released during trauma or tissue injury
Noxious stimuli and inflammatory recognition pathways
trigger activation of different receptor types shared by
cells of the immune and peripheral nervous systems. In
particular, TRP channels recognize exogenous signals,
DAMPs from the environment (for example, heat, acidity,
chemicals) and endogenous danger signals released during
trauma/tissue injury (for example, ATP, osmotic stress,
uric acid, hydroxynonenals). Other types of cellular stress
such as mechanical stress can be also sensed by TRP
channels and can induce inflammation [38].
Local extracellular acidosis may promote inflammation at
ischemic and inflammatory sites. Acidic extracellular pH
triggers NLRP3 inflammasome activation and IL-1β secre-
tion in human macrophages and represents a novel danger
signal alerting the innate immunity [39]. The NLRP3
inflammasome complex triggers caspase-1-mediated mat-
uration and secretion of IL-1β, one of the key proinflamma-
tory cytokines. Rajamäki and colleagues have demonstrated
that human macrophages exposed to pH 7.5 to 6.0 trigger a
pH-dependent secretion of IL-1β and activation of caspase-
1 through a mechanism involving the TRPV1 and K+
channels. Acidic extracellular pH causes rapid intracellular
acidification and IL-1β-inducing effects. Moreover, the
NLRP3 knockdown abolishes IL-1β secretion at acidic pH.
Remarkably, alkaline extracellular pH inhibited IL-1β re-
sponse to different NLRP3 activators. Overall these datasuggest that acidic environment represents an endogenous
danger signal alerting the innate immunity. Low pH con-
tributes to the start of inflammation in acidosis-associated
pathologies such as atherosclerosis, post-ischemic inflam-
matory responses and cancers [39]. Intracellular acidifica-
tion evoked by extracellular acidosis is regulated through
TRPV1 [40]; thus a role for this receptor in the transduc-
tion of acidic danger signals activating the inflammasome
might be suggested.
TRPM8 receptor is differentially expressed in human
immune cells and in primary sensory neurons [41,42].
Increased transcription of IL-1α, IL-1β, IL-6, and IL-8
cytokine genes in human lung epithelial cells through
activation of a TRPM8 variant by exposure to cold tem-
peratures has been reported [43]. Moreover, in a recent
abstract presented at the ISSAID Congress 2013 by
Stoffels and colleagues it has been hypothesized that
in vivo cold exposure could result in a modulated in-
flammatory response through activation of temperature-
sensitive ion channels [44]. Thus, exposure to cold, or
ex vivo stimulation of peripheral blood mononuclear
cells with menthol, a TRPM8 agonist, induces an exagger-
ated (local and systemic) cytokine inflammatory response,
as evaluated at protein level by enzyme-linked immuno-
sorbent assays in several human-derived cell lines, primary
cells and skin biopsies. Activation of the temperature-
sensitive TRPM8 channel via TLRs results in an enhanced
IL-1β secretion and, likely, NLRP3 inflammasome forma-
tion [44].
Exposure to particulate crystals can induce oxidative
stress in phagocytes, which triggers NLRP3 inflammasome-
mediated IL-1β secretion, activating undesiderable inflam-
matory responses associated with both autoinflammatory
and metabolic diseases. Although mitochondrial ROS have
been found to play a central role in NLRP3 inflammasome
activation, how the ROS signal causes NLRP3 assembly of
the inflammasome is still unknown. Recently, it has been
demonstrated that liposome activation of the NLRP3
inflammasome requires mitochondrial ROS. Stimulation
of macrophages with liposomes/crystals induces ROS-
dependent calcium influx via the TRPM2 channels, and
macrophages deficient in TRPM2 display impaired NLRP3
inflammasome activation and IL-1β secretion [45,46]. In
this regard, Trpm2−/− mice were resistant to crystal-/lipo-
some-induced IL-1β-mediated peritonitis in vivo. Moreover,
TRPM2-deficient mice are also susceptible to Listeria
monocytogenes infection [47], a known activator of NLRP3
inflammasome [48]. Therefore, targeting TRPM2 may be
effective for treatment of NLRP3 inflammasome-associated
inflammatory disorders. Recently, a close interaction be-
tween ER and mitochondria in response to NLRP3 inflam-
masome stimuli has been demonstrated [49]. Interestingly,
Murakami and colleagues have showed that ER-derived cal-
cium is essential for mitochondria to maintain a damaged
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chondrial DNA into the cytosol, which activates the
inflammasome [51,52]. ROS released from damaged mito-
chondria activate the TRPM2 channel, which results in
calcium influx across the plasma membrane. Thus, it ap-
pears that calcium mobilization represents a critical step
during NLRP3 inflammasome activation. Calcium is a key
signal for several cellular proteases, protein kinases and
phospholipases involved in NLRP3 inflammasome activa-
tion. These calcium-dependent enzymes may proteolytic-
ally regulate the assembly of the NLRP3 inflammasome.
TRPA1 seems to be involved in the detection of react-
ive chemicals, including environmental irritants such as
tear gas and industrial isothiocyanates; it is also activated
during tissue injury by endogenous 4-hydroxynonenal
and prostaglandins [53,54]. A role for this receptor in
the inflammasome activation is in evaluation.
The role of TRPM7 and TRPV2 channels in osmotic
stress and regulatory volume decrease responses
in microglia
Changes in cell volume represent a specific signal in the
regulation of important physiological processes [55,56].
Cells exhibit rapid volume-regulatory mechanisms to re-
cover their functions in response to different signals. Al-
terations in osmosensing or osmosignaling are associated
with ischemia, hyponatremia, hypothermia and intracellu-
lar acidosis [55,57]. Hypotonicity has been found to
induce processing and release of IL-1β [58]. Low osmolar-
ities stimulate macrophage swelling and a decrease in
intracellular K+ and Cl− levels, which activates a regulatory
volume decrease (RVD) that is sensed by the NLRP3
inflammasome [59]. The RVD process is controlled by
TRPM7 and TRPV2 channels expressed in macrophages.
During RVD, TRPV2 is translocated to the plasma mem-
brane where it induces permeabilization [60]. Hypoton-
icity induces lysosome destabilization and it is sensitive to
a broad range of TRP channel blockers that suppress
caspase-1 activation and IL-1β release. TRPV2 functions
as an osmosensor, and TRPM7 as a controller of the RVD
process [61-63]. Blocking TRPM7 function using high
extracellular Mg2+ concentrations delays RVD, decreases
cell permeabilization [64], and reduces IL-1β release in
macrophages. In the THP-1 monocytic cell line, TRPV2
gene silencing decreases IL-1β release in response to
hypotonicity, without affecting RVD [60]. A decrease in
extracellular osmolarity induces phosphorylation and acti-
vation of TAK1 (transforming growth factor-β activated
kinase-1) in the HeLa cell line [65]. Inhibition of TAK1
phosphorylation abrogates hypotonicity-induced caspase-
1 activation and IL-1β processing and activation of TAK1
is abolished in the presence of BAPTA-AM, a selective
Ca2+ and Mg2+ chelator, suggesting a pivotal role for TRP
channels. Moreover the TRP channel inhibitor 2-APB isable to block TAK1 phosphorylation and, in TAK1-
silenced cells, IL-1β release induced by hypotonicity is also
reduced in macrophages [60].
It has been reported that membrane stretch and intracel-
lular Ca2+ activate TAK1 [66,67]. After maximum stretch
during cell swelling, endomembranes, derived from endo-
somes and lysosomes, are used to repair plasma membrane
damage [68]. In macrophages, endomembrane fusion dur-
ing RVD induces TRPV2 trafficking to the cell surface. TRP
blockers are also effective in inhibiting monosodium urate
(MSU) crystal- and nigericin-induced caspase-1 activation,
but the specific involvement of TRP channels, particularly
of TRPV2, in NLRP3 activation has still to be confirmed
using genetic ablation in mouse models [69]. Overall,
general blockers of TRP channels abolish the RVD (prob-
ably controlled by TRPM7), cell permeabilization (due to
TRPV2) and caspase-1 activation.
TLR-mediated inflammatory response is
associated with TRP channel-dependent Ca2+
signaling and inflammasome activation in
immune cells
Intracellular Ca2+ represents a second messenger that
participates in TLR4-dependent signaling; however, how
intracellular Ca2+ is increased in response to microbial
stimuli (for example, LPS) and how it affects the inflam-
matory response and inflammasome generation is still
only partially understood.
Several studies have indicated that TLR-mediated immune
responses are associated with TRP channel-dependent Ca2+
signaling. Tauseef and colleagues identified a function for
TRPC6 in endothelial cells (ECs). They showed that
TRPC6-dependent Ca2+ signaling was coupled with the
TLR4 signaling pathway and hence contributing to LPS-
induced EC permeability and NF-κB-dependent lung in-
flammation [70]. Deletion of TRPC6 renders mice resistant
to this endotoxin-induced barrier dysfunction and inflam-
mation, and protects against sepsis-induced lethality. In
addition, they found that LPS induces diacylglycerol in ECs,
which activates TRPC6 in a TLR4-dependent manner.
TRPC6-mediated Ca2+ entry in turn activates myosin light
chain kinase, a regulator of endothelial contractility [70].
Recently, in RAW264 macrophages, it has been shown that
TRPV2-mediated intracellular Ca2+ mobilization is involved
in LPS-induced expression of inflammatory cytokines
(tumor necrosis factor-α and IL-6) in a NF-κB-dependent
manner [71]. Thus, it is tempting to speculate a role for
TRPV2 in modulating TLR4-dependent signaling. Among
TRPMs, TRPM4 is involved in LPS-induced EC death, and
inhibition of TRPM4 activity protects the endothelium
against LPS injury [72].
Higher levels of inflammasome components have been
detected in the gingival tissues from patients with chronic
periodontitis. Data obtained in differentiated THP-1 cells
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gen involved in the pathogenesis of periodontitis [73], evi-
denced that the microorganism induces IL-1β secretion,
caspase-1 activation and pyroptotic cell death through
both NLRP3 and AIM2 inflammasome activation [74].
The activation of the NLRP3 inflammasome is mediated
by ATP release, P2X7 receptor and lysosomal damage. In
addition, the priming signal is triggered via TLR2 and TLR4
activation precede P. gingivalis-induced IL-1β release [74].
Moreover, the expression of TRPV1 and TLR4 found in
keratinocytes, fibroblasts, inflammatory cells and capillary
endothelial cells in patients with aggressive and chronic peri-
odontitis [75] suggests a role for TRPV1 signaling in the in-
duction of the NLRP3 inflammasome.
Membrane TLRs respond to specific microbial compo-
nents, including proteins of the virus envelopes, inducing
cytokine release. The envelope protein hemagglutinins of
MV (Measles Virus) and fusion protein of RSV (Respira-
tory Syncytial Virus) are known to interact with TLR2 and
TLR4, and this effect upregulates TRP channels [76]. In
particular RSV, MV and RV (Rhinovirus) induce TRPV1
and TRPA1 upregulation in bronchial epithelium, airway
nerves and smooth muscle cells, with higher levels in
asthmatic patients. Early upregulation of TRPA1 and
TRPV1 expression in differentiated IMR-32 neuroblast-
oma cells is evidenced at 2 to 4 hours post-RV HRV-16 in-
fection. This effect is independent of replicating virus, as
virus-induced soluble factor alone is sufficient to increase
TRP channel expression and augment nerve growth factor
(NGF), IL-6, IL-8 and IL-1β levels in the supernatant of
infected cells. By contrast, TRPM8 expression is maximal
at 48 hours, and requires virus replication rather than sol-
uble factors [76].
Further studies are required to completely understand
the relationship between TLRs and TRP channels, cyto-
kines, inflammasome activation and inflammatory response
generation. The understanding of these interactions is cru-
cial, as they may represent a novel potential therapeutic
target and strategy for the treatment of chronic or acute in-
flammatory diseases by using TRPV1 and/or TRPA1
antagonists.
Danger recognition pathways in the peripheral
nervous system and potential role of TRP
channels in the inflammasome responses
During tissue damage and pathogenic infections, release
of danger signals lead to a coordinated activation of an in-
tegrated host defense formed by both peripheral neurons
and immune cells which activates a complex bidirectional
communication through synthesis or release of neuropep-
tides, neurotransmitters, hormones and cytokines. Periph-
eral sensory neurons are adapted to recognize danger by
virtue of their sensitivity to intense mechanical, thermal
and irritant chemical stimuli. In this regard, TRP ionchannels are the most widely studied molecular mediators
of nociception, conducting non-selective entry of cations
upon activation by various noxious stimuli [77]. The ana-
tomic position of sensory neurons at the interface with the
environment, their ability to release a set of immune-acting
mediators and the velocity of neural signal transduction al-
lows the peripheral nervous system to immuno-modulate
the innate and adaptive responses. By contrast, sensory
neurons are very sensitive to immune mediators, which
trigger and sensitize neurons [77]. Thus, neurogenic and
immune-mediated types of inflammation act together as
early warning devices. Nociceptor neurons in the peripheral
nervous system possess many of the same molecular recog-
nition pathways for danger as immune cells, and the line
between PRRs and noxious ligand-gated ion channels is in-
creasingly blurred.
Peripheral and terminal axons have been found to induce
a rapid and local release of neural mediators during the
neurogenic inflammation, independently of that produced
by the immune cell system. Neuropeptides, such as calci-
tonin gene-related peptide (CGRP) and substance P, adre-
nomedullin, neurokinins A and B, vasoactive intestinal
peptide, neuropeptide Y, and gastrin-releasing peptide, as
well as glutamate, nitric oxide, and cytokines and chemo-
kines [78] from nociceptors, directly attract and activate in-
nate and adaptive immune cells [79-81]. In this regard, it
has been hypothesized that substance P is able to activate
the NALP1 inflammasome. Furthermore, LY303870, a NK1
receptor antagonist, blocked the upregulation of activated
NALP1 inflammasome components and IL-1β and IL-18
generation in a rat fracture model of complex regional pain
syndrome [82].
Another key component of the immune/sensory neuron
communication system are cytokines. In early phases of
inflammation, sensory neurons signal to tissue resident
mast cells and dendritic cells to induce degranulation or
cytokine production [79,83]. IL-1β and tumor necrosis
factor-α released by innate immune cells are directly sensed
during inflammation by nociceptors which express the cog-
nate receptors [84-86]. Upon activation of cytokine recep-
tors, signal pathways are activated in nociceptors, inducing
activation of membrane proteins including TRP channels
[77]. The consequent sensitization of sensory neurons
means that innocuous mechanical and heat stimuli can
trigger nociceptors. Interestingly, sensory neurons share
many of the same pathogen and danger molecular recogni-
tion receptor pathways as innate immune cells, which en-
able them also to recognize pathogens [77]. As in the
immune system, sensory neurons express PRRs including
TLR3/4/7/9, and stimulation by their ligands induces in-
ward currents and nociceptor sensitization [87-89]. Activa-
tion of sensory neurons by the TLR7 ligand imiquimod
leads to activation of an itch-specific sensory pathway [87].
A functional expression of the IL-31RA receptor, showing a
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cells and sensory neurons for the generation of T-cell medi-
ated itch, was evidenced in a small subpopulation of IL-
31RA(+)/TRPV1(+)/TRPA1(+) neurons [90]. In addition
extracellular microRNAs (let-7b miRNA) via the TLR7 re-
ceptor that couples TRPA1 activates nociceptor neurons to
elicit pain [91]. TLR4 also enhances histamine-mediated
pruritus by potentiating TRPV1 activity in dorsal root gan-
glion (DRG) sensory neurons [92]. Furthermore, in trigemi-
nal neurons, LPS sensitizes TRPV1 to capsaicin, which is
blocked by a selective TLR4 antagonist [88]; LPS or P. gin-
givalis infection has been demonstrated to increase
capsaicin-evoked release of CGRP and TRPV1 sensitization
in capsaicin-sensitive nociceptors [93] and down-regulates
NLRP3 inflammasome expression [94]. Respiratory virus
infections can upregulate TRPV1 and TRPA1 in airway
nerves with higher expression levels in asthmatic patients
[76]. Overall, these data suggest the expression of a
TRPV1/CGRP/TLR4 axis mediating a cross-talk between
neural and immune receptors during innate immune re-
sponses through the peripheral release of neuronal signal-
ing molecules, and the induction of infection-associated
pain and itch may be partly due to direct activation of neu-
rons by pathogen-derived factors. In addition, endotoxin by
inducing TLR4 activation of TRPC6-dependent calcium
signaling induces vascular permeability and inflammation
in the lung [70].
Amongst the DAMP/alarmin, extracellular ATP repre-
sents the major signals recognized by sensory neurons. It is
a potent danger signal that activates both peripheral neurons
during cellular injury, and some evidence even suggests that
neurons express components of the inflammasome molecu-
lar machinery [95]. The ATP is recognized by purinergic
and TRP receptors on both nociceptor neurons [96,97]. Pur-
inergic receptors are made up of two families: P2X receptors
(ligand-gated cation channels) and P2Y receptors (G-protein
coupled receptors). In nociceptor neurons, recognition of
ATP through P2Y receptors contributes to nociceptor acti-
vation by TRP sensitization. Thus, in sensory neurons, the
triggering of P2Y2 receptor by ATP activates the TRPV1
channel in the absence of any other stimuli [98]. In
macrophages, ATP binding to P2X7 receptors induces hy-
perpolarization and downstream activation of the inflam-
masome [99].
In addition, MSU or H2O2 injection into the hind paws of
rodents or application to sensory neurons increased the ex-
pression of TRPA1 and TRPV1, and enhanced cellular infil-
tration and IL-1β levels; these effects were blocked by
TRPA1 antagonists [100]. Moreover, MSU-induced pain-like
behavior, hyperalgesia, allodynia, articular edema as well as
plasma extravasation, leukocyte infiltration and IL-1β pro-
duction were inhibited by co-administration of a selective
TRPV1 antagonist, SB366791 [101]. Mechanical hypersensi-
tivity evoked by intraplantar injection of LPS was preventedby the TRPA1 antagonist (AP-18) and was absent in
Trpa1(−/−) mice, indicating that H2S-mediated stimula-
tion of TRPA1 is necessary for local pro-nociceptive ef-
fects of LPS [102].
Inflammasome-forming NLRs in neurons of central
nervous system and TRP channel involvement in
neurodegenerative diseases
Inflammation in the central nervous system (CNS) has both
pathogenic and protective effects depending on the clinical
context. Increasing evidence suggests that inflammasomes
exist in CNS cells such as neurons, astrocytes and micro-
glia. Inflammasomes function as intracellular sensors for in-
fectious agents as well as for host-derived danger signals
and several studies have reported caspase-1 activation, IL-
1β cleavage and expression of inflammasome-forming
NLRs in neurons [60,103-106], as well as NLRP2 inflamma-
some expression in astrocytes [107]. The activation of the
inflammasomes in the CNS are involved in the generation
of an innate immune inflammatory response through IL-1β
and IL-18 cytokine release and in cell death through the
process of pyroptosis [108]. In the CNS, microglia, astro-
cytes and neurons express receptors for these cytokines,
which thereby participate in systemic responses such as
fever as well as in local inflammation within neural tissue
[109,110].
Inflammasome activation is under current investigation
across a broad spectrum of neurological diseases including
infections, acute sterile brain injury and chronic neurode-
generative diseases. For a timely and extensive discussion on
inflammasomes in CNS degenerative diseases, we direct the
reader to a recent review by Walsh and colleagues, pub-
lished in 2014 in Nature Review Neuroscience [108].
Perturbations of neuronal Ca2+ homeostasis are in-
volved in the pathogenesis of several neurodegenerative
disorders [111,112]. Thus, in amyotrophic lateral scler-
osis/Parkinson dementia, high oxidative stress induces
TRPM2 as well as TRPM7 activation leading to neurode-
generation [113]; in Parkinson's disease, dopaminergic
neurons, along with coupling of mGluR1 with TRPC1/3/5
channels, results in alteration of neuronal activity
[114,115]. TRPV1 and TRPV2 agonists diminished dopa-
mine depletion and tyrosine hydroxylase deficits caused
by the neurotoxin 6-hydroxydopamine in the striatum
[116] and overexpression of TRPC1 increased dopamin-
ergic neuron survival following MPP neurotoxin adminis-
tration [117]. TRPM7-associated Mg2+-inhibited cation
channel activity plays a role in neurodegenerative variations
associated with Alzheimer's disease (AD) [118]; in AD,
presenilin-2 negatively influences the TRPC6-dependent
calcium entry [119] and inhibition of TRPM2 by siRNA re-
duces amyloid-β toxicity, suggesting a role for TRPM2 in
neuronal cell death [120]. By contrast, in AD activation of
TRPM7 leads to zinc accumulation and zinc-induced
Santoni et al. Journal of Neuroinflammation  (2015) 12:21 Page 7 of 10neurotoxicity [121]. TRPM2 and TRPM7 contribute to is-
chemic neural death and dysfunction, and their inhibition
or gene silencing increased neuronal survival during ische-
mia [122].
Inflammasome proteins and even the functional ma-
chinery of inflammasomes have been linked to cell death
in several cell types [123]. Tissue damage caused by oxida-
tive stress has been found to play a pathogenetic role in
several chronic neurodegenerative diseases such as AD
and Parkinson’s disease. Substantial evidence supports the
conclusion that TRP channels, in particular the TRPM2
channel, link cell death induced by oxidative stress [120]
with the NLRP3 inflammasome activation [124].
Amyloid-β, the chief constituent of senile plaques in Alz-
heimer’s disease, was the first molecule associated with a
neurodegenerative disease to be shown to activate the
inflammasome (for example, NLRP3) [125,126]. Amyloid β-
peptide and H2O2 have been found to induce cell death in
primary cultures of rat striatal cells which express TRPM2Table 1 DAMP/PAMP recognition by TRP channels and PRRs t
neuron cells
DAMP/PAMP TRP channel/s Immune cells N
Acid pH TRPV1 Macrophages
Cold TRPM8 PBMCs N
Liposome/crystals TRPM2 Phagocytes
RVD TRPV2 Macrophages
TRPM7 Macrophages
Osmotic stress TRPV2 Dendritic cells
MSU/alum TRPV2 Monocytes
TRPA1 S
TRPV1 N
ATP P2Y2/TRPV1 S
miRNA TLR7/TRPA1 S
Mechanical stretch TRPC3 Monocytes
Ca2+ TLR4-TRPC6 E
RV TRPA1 N
TRPV1
TRPM8
RSV/MS TLR2/4-TRPV1 E
TLR2/TRPA1 S
TLR2/4-TRPM8 N
PG TLR2/4-TRPV1 Monocytes
Macrophages
TLR4-TRPV1 S
LPS TLR4/TRPC6 S
?, Suggested, but not yet identified; AIM2, absent in melanoma 2; DAMP, danger-as
MV, Measles virus; NLRP3, NOD-like receptor family, pyrin domain-containing 3; P2Y
molecular pattern; PBMC, peripheral blood mononuclear cell; PG, Porphyromonas gi
decrease; TLR, Toll-like receptor; TRP, transient receptor potential; TRPM2, TRP Mela
TRPA1, TRP Ankyrin-like protein with transmembrane-like domain 1; TRPC3, TRP Can[120]. Four physiological splice variants of TRPM2 have
been identified at present: TRPM2-L (full length or wild-
type), TRPM2-S, TRPM2-ΔN and TRPM2-ΔC [127]. In stri-
atal cells, the dominant negative splice variant TRPM2-S
inhibits both amyloid β-peptide and H2O2-induced increase
in [Ca2+]i and protects cell viability. Moreover, reduction in
endogenous TRPM2 levels by RNA interference significantly
enhances cell viability after β-peptide and H2O2 treatment.
Overall, these data provide significant support to the con-
clusion that TRPM2 is involved in oxidative stress-induced
injury to striatal cells and, through activation by amyloid β-
peptide, may be involved in the pathogenesis of AD [127].
Further studies may be required to completely assess
the involvement of TRP channel signaling in inflamma-
some activation in neurodegenerative diseases.
Conclusions
Overall, the findings recently reported strongly suggest an
important role played by ion channels belonging to theriggers the inflammasome activation in immune and
on-immune cells Type of inflammasome Reference
NLRP3 [39]
eurons ? [44]
NLRP3 [123]
NLRP3 [128]
NLRP3 [60]
NLRP3 [16]
NLRP3 [59]
ensory neurons ? [100]
eurons ? [100]
ensory Neurons ? [98]
ensory neurons ? [91]
? [129]
ndothelial cells ? [70]
euroblastomas NLRP3 [76]
pithelial cells NLRP3 [76]
mooth muscle cells NLRP3 [76]
euroblastomas NLRP3 [76]
NLRP3 [74]
AIM2 [74]
ensory neurons ? [88,93]
ensory Neurons ? [70]
sociated molecular pattern; LPS, lipopolysaccharide; MSU, monosodium urate;
2, Purinergic receptor P2Y G-protein coupled 2; PAMP, pathogen-associated
ngivalis; RV, Rhinovirus; RSV, Respiratory syncytial virus; RVD, regulatory volume
statin type-2; TRPM7, TRP Melastatin type 7; TRPM8, TRP Melastatin type-8;
onical type-3, TRPV1, TRP vanilloid type-1; TRPV2, TRP Vanilloid type-2.
Santoni et al. Journal of Neuroinflammation  (2015) 12:21 Page 8 of 10TRP channel families that mediates interchanged and bi-
directional contact and intracellular signals with known
PAMPs and DAMPs in inflammasome activation in im-
mune and sensory nervous cells (Table 1). The develop-
ment of new drugs to target inflammasome functions are
now promising possibilities for future therapeutic inter-
ventions in neurological diseases. These results highlight
the therapeutic potential of targeting different TRP chan-
nels by using TRP antagonists, or different molecules able
to inhibit the TRP-induced signaling pathway, in autoin-
flammatory and metabolic disorders associated with un-
desirable activation and generation of the inflammasome.
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